• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 354-368 of 901 results

1080 Exhibit: NCT01933490, CLINICALTRIALSGOV

Document IPR2024-00009, No. 1080 Exhibit - NCT01933490, CLINICALTRIALSGOV (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1052 Exhibit: Madsbad, An Overview, 13 DIABETES, OBESITY METABOLISM 394...

Document IPR2024-00009, No. 1052 Exhibit - Madsbad, An Overview, 13 DIABETES, OBESITY METABOLISM 394 2011 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1043 Exhibit: US Patent App Pub 20040102486

Document IPR2024-00009, No. 1043 Exhibit - US Patent App Pub 20040102486 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1075 Exhibit: US Patent No 7,022,674

Document IPR2024-00009, No. 1075 Exhibit - US Patent No 7,022,674 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1097 Exhibit: Mylan Pharma Inc, v Novo Nordisk IPR2023 00724, Paper 10, Oct 4, ...

Document IPR2024-00009, No. 1097 Exhibit - Mylan Pharma Inc, v Novo Nordisk IPR2023 00724, Paper 10, Oct 4, 2023 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1082 Exhibit: Scheduling Order, No 22 294 CFC, D Del June 30, 2022, ECF No 22

Document IPR2024-00009, No. 1082 Exhibit - Scheduling Order, No 22 294 CFC, D Del June 30, 2022, ECF No 22 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1029 Exhibit: Jimenez Solem, Dulaglutide, 12 current OP in Molecular Therap 90 20...

Document IPR2024-00009, No. 1029 Exhibit - Jimenez Solem, Dulaglutide, 12 current OP in Molecular Therap 90 2010 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1049 Exhibit: Intl Conf on Harmonisation, 59 Fed Reg 55972 Nov 9, 1994

Document IPR2024-00009, No. 1049 Exhibit - Intl Conf on Harmonisation, 59 Fed Reg 55972 Nov 9, 1994 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1095 Exhibit: Declaration of Dr Maureen M Donovan

Document IPR2024-00009, No. 1095 Exhibit - Declaration of Dr Maureen M Donovan (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1051 Exhibit: Landersdorfer, Pharmacokinetic 477 CLINICAL PHARMACOKINETIC...

Document IPR2024-00009, No. 1051 Exhibit - Landersdorfer, Pharmacokinetic 477 CLINICAL PHARMACOKINETICS 417 2008 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1073 Exhibit: US Patent No 6,458,924

Document IPR2024-00009, No. 1073 Exhibit - US Patent No 6,458,924 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1044 Exhibit: Rohatagi, Model Based Development, 48 J CLINICAL PHARMACOLO...

Document IPR2024-00009, No. 1044 Exhibit - Rohatagi, Model Based Development, 48 J CLINICAL PHARMACOLOGY 1420 2008 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1078 Exhibit: US Patent App Pub No 20040102486

Document IPR2024-00009, No. 1078 Exhibit - US Patent App Pub No 20040102486 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1031 Exhibit: Knudsen, GLP 1 Derivatives, 26 DRUGS OF THE FUTURE 677 2001

Document IPR2024-00009, No. 1031 Exhibit - Knudsen, GLP 1 Derivatives, 26 DRUGS OF THE FUTURE 677 2001 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze

1050 Exhibit: Garber, Efficacy of Metformin in Type II Diabetes,102 JMED 491 1997

Document IPR2024-00009, No. 1050 Exhibit - Garber, Efficacy of Metformin in Type II Diabetes,102 JMED 491 1997 (P.T.A.B. Oct. 20, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 24 25 26 27 28 ... >>